Utilizing 131I as a radiotherapeutic nuclide and monoclonal antibody B7-H3 (4H7) as a carrier, the feasibility and efficacy of B7-H3-mediated 131I-4H7 targeted radiotherapy was analyzed in a human RCC xenograft model. The gene discussed is CD276; the disease is renal cell carcinoma.